Article
The CD28-transmembrane domain mediates chimeric antigen receptor heterodimerization with CD28
2020-09-19
Abstract excerpt
Anti-CD19 chimeric antigen receptor (CD19-CAR)-engineered T cells are approved therapeutics for malignancies. The impact of the hinge (HD) and transmembrane (TMD) domains between the extracellular antigen-targeting and the intracellular signaling modalities of CARs has not been systemically studied. Here, a series of CD19-CARs differing only by their HD (CD8/CD28/IgG 4 ) and TMD (CD8/CD28) was generated. CARs con...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6742bdd7-bee2-546e-8fc0-9d07a6401d7c
- DOI
- 10.1101/2020.09.18.296913
